华邦健康：子公司糠酸莫米松乳膏获得药品注册证书

Core Viewpoint - Huabang Health's subsidiary Huabang Pharmaceutical has received approval from the National Medical Products Administration for the drug registration certificate of Mometasone Furoate Cream in two specifications, indicating a significant regulatory milestone for the company [1] Company Summary - Huabang Pharmaceutical's Mometasone Furoate Cream is primarily used for treating eczema, neurodermatitis, atopic dermatitis, and pruritus [1] - The drug was registered as a Class 3 chemical generic drug, which is considered equivalent to passing the consistency evaluation [1]